Evidence
Am J Crim Justice. 2022 Nov 14:1-21. doi: 10.1007/s12103-022-09701-9. Online ahead of print.
ABSTRACT
Despite declines in prescription opioid overdoses, rural areas continue to have higher prescription opioid overdose rates than urban areas. We aim to understand high overdose places were resilient to the prescription opioid overdose crisis (better than predicted), while others were vulnerable (worse than predicted). First, we predicted prescription opioid overdose mortality in 2016-18 for N = 2,013 non-metropolitan counties using multivariable regression accounting. Second, we constructed a resiliency-vulnerability typology using observed, predicted, and residual values from the regression. Third, we selected a high-overdose resilient and vulnerable community for case study analysis using interviews, focus groups, and observations. High-overdose resilient and vulnerable places had disability-dispensing-overdose pathways, legacies of mining, and polysubstance drug abuse. Resilient places were larger population micropolitans with extensive health and social services, norms of redemption and acceptance of addiction, and community-wide mobilization of public and non-profit resources. Vulnerable places were smaller, more remote, lacked services, and stigmatized addiction.
PMID:36407839 | PMC:PMC9660123 | DOI:10.1007/s12103-022-09701-9
Add to Google Keep
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
Prescription Opioid Resiliency and Vulnerability: A Mixed-Methods Comparative Case Study
🌐 90 Days
VR Related Evidence Matrix
- Overdose from Unintentional Fentanyl Use when Intending to Use a Non-opioid Substance: An Analysis of Medically Attended Opioid Overdose Events
- "Naloxone? Not for me!" First cross-assessment by patients and healthcare professionals of the risk of opioid overdose
- Higher First 30-Day Dose of Buprenorphine for Opioid Use Disorder Treatment Is Associated With Decreased Mortality
- Association of Disability Status and Type With Binge Drinking and Prescription Opioid Misuse Among Adults From a 3-State Sample
- Trauma-related shame predicts daily non-medical prescription opioid use among individuals with PTSD symptoms
- Declining but Pronounced State-Level Disparities in Prescription Opioid Distribution in the United States
- Blood pressure response to extended-release naltrexone in heroin and prescription opioid users and its implications for cardiovascular morbidity
- The Clinical Evolutions of Surveillance and Violence During Three Contemporary US Crises: Opioid Overdose, COVID-19, and Racial Reckoning
- Emergency Room Utilization and Methamphetamine Overdose Symptoms Among Syringe Services Program Participants in Washington State
- Equity of overdose education and naloxone distribution provided in the Kentucky HEALing Communities Study
- Prescription opioid dispensing patterns among patients with schizophrenia or bipolar disorder
- Using alone at home: What's missing in housing-based responses to the overdose crisis?
- Trends in fatal opioid-related overdose in American Indian/Alaska Native Communities 1999-2021
- An interpretable machine learning framework for opioid overdose surveillance from emergency medical services records
- Opioid Management Review Committee: Fostering Interdisciplinary Education and Support Amid the Ongoing US Opioid Overdose Crisis
- National Institute on Drug Abuse Clinical Trials Network Meeting Report: Managing Patients Exposed to Xylazine-Adulterated Opioids in Emergency, Hospital and Addiction Care Settings
- Users' Acceptability and Perceived Efficacy of mHealth for Opioid Use Disorder: Scoping Review
- The fentanyl-specific antibody FenAb024 can shield against carfentanil effects
- Association of state-level prescription drug monitoring program implementation with opioid prescribing transitions in primary care in Australia
- Associations between cannabis use, opioid misuse and severe psychological distress in adolescents: A cross-sectional school-based study.Cannabis, opioids, and mental health
- Fact vs. fiction: naloxone in the treatment of opioid-induced respiratory depression in the current era of synthetic opioids
- Real-World Evidence for Impact of Opioid Agonist Therapy on Nonfatal Overdose in Patients With Opioid Use Disorder During the COVID-19 Pandemic: Erratum
- Mortality risk and causes of death among people who use opioids in a take-home naloxone cohort
- Regional differences in fatal drug overdose deaths among Black and White individuals in the United States, 2012-2021
- Effect of a Co-Located Bridging Recovery Initiative on Hospital Length of Stay Among Patients With Opioid Use Disorder: The BRIDGE Randomized Clinical Trial
- Self-reported pain severity and use of cannabis and opioids in persons with HIV in an urban primary care setting in Northern California: A cross-sectional study
- Referral to and engagement in substance use disorder treatment within opioid intervention courts in New York: a qualitative study of implementation barriers and facilitators
- Age-Related Risk of Serious Fall Events and Opioid Analgesic Use
- Buprenorphine misinformation and willingness to treat patients with opioid use disorder among primary care-aligned health care professionals
- Establishing a research agenda for the study and assessment of opioid withdrawal
- Take-Home Naloxone Access and Use among Older Adults Living with Pain: A Scoping Review
- Patient perspectives on mental health and pain management support needed versus received during opioid deprescribing
- Opioid-induced hypogonadism in opioid use disorder, its role in negative reinforcement, and implications for treatment and retention
- Association of anxiety and depression symptoms with perceived health risk of nicotine vaping products for smoking cessation
- Primary prevention of prescription stimulant misuse in first-year college students
- An Approach to Enhancing Medication Treatment for Opioid Use Disorder in the HEALing Communities Study
- Opioid overdose after extended-release buprenorphine injection: a case report
- Medication-based treatment among rural, primary care patients diagnosed with opioid use disorder and alcohol use disorder
- Mental Health and Addiction Data Use Cases: Macro Perspectives in Ontario
- Substance use patterns, sociodemographics, and health profiles of harm reduction service recipients in Burlington, Vermont
- Evaluation of a Pilot Program to Prevent the Misuse of Prescribed Opioids Among Health Care Workers: Repeated Measures Survey Study
- Impact of the Communities That HEAL Intervention on Buprenorphine-Waivered Practitioners and Buprenorphine Prescribing: A Prespecified Secondary Analysis of the HCS Randomized Clinical Trial
- Cost of start-up activities to implement a community-level opioid overdose reduction intervention in the HEALing Communities Study
- Cost of start-up activities to implement a community-level opioid overdose reduction intervention in the HEALing Communities Study
- Suicide Rates and Prescription of Antidepressants
- Characterizing Acute and Postsurgical Pain Management in Patients Receiving Buprenorphine or Buprenorphine/naloxone
- Opioids and Youth Athletes
- Peptide-derived ligands for the discovery of safer opioid analgesics
- Social Determinants of Health and Continuity of Medications for Opioid Use Disorder Among Patients Receiving Treatment in Rural Primary Care Settings
- Perceptions of prospective pharmaceutical stimulant substitution treatments among people who use illicit stimulants in Vancouver, Canada
- Short- and long-term safety of discontinuing chronic opioid therapy among older adults with Alzheimer's disease and related dementia
- Opioids in geriatric units in 14 Belgian hospitals: prevalence, dosage and associated factors
- Neuropsychiatric Effects Associated with Opioid-Based Management for Palliative Care Patients
- Buprenorphine: two adolescent case reports of bridging the transmucosal form to the extended-release subcutaneous injectable form
- Detecting DSM-5 Opioid and Methamphetamine Use Disorders With the UNCOPE Screen
- Impact of prescribed opioid use on development of dementia among patients with chronic non-cancer pain
- Impact of prescribed opioid use on development of dementia among patients with chronic non-cancer pain
- An Overview of the CRoME Lab's MedSMA℞T Families Intervention for Promoting Opioid Medication Safety among Adolescents and Parents
- "It gets you high as a kite but not unsick": Characterizations of and responses to a changing local drug supply by people who use drugs in Rhode Island
- Timing of treatment for opioid use disorder among birthing people
- Identification of Myths and Misinformation About Treatment for Opioid Use Disorder on Social Media: Infodemiology Study
- The association of pain impact and sleep disruption with opioid withdrawal during opioid-use disorder treatment
- Problem Opioid Use Among US Military Veterans: Prevalence, Correlates, and Psychiatric Characteristics
- Impact of the Narcotics Information Management System on Opioid Use Among Outpatients With Musculoskeletal and Connective Tissue Disorders: Quasi-Experimental Study Using Interrupted Time Series
Evidence Blueprint
Prescription Opioid Resiliency and Vulnerability: A Mixed-Methods Comparative Case Study
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Prescription Opioid Resiliency and Vulnerability: A Mixed-Methods Comparative Case Study
🌐 365 Days
VR Related Evidence Matrix
- Understanding Regional Patterns of Overdose Deaths Related to Opioids and Psychostimulants
- Comparing the effects of decreasing prescription opioid shipments and the release of an abuse deterrent OxyContin formulation on opioid overdose fatalities in WV: an interrupted time series study
- Predictors of fatal and nonfatal overdose after prescription of opioids for chronic pain: a systematic review and meta-analysis of observational studies
- Buprenorphine and opioid analgesics: Dispensation and discontinuity among accidental overdose fatalities in the Indianapolis metropolitan area, 2016-2021
- Overdose from Unintentional Fentanyl Use when Intending to Use a Non-opioid Substance: An Analysis of Medically Attended Opioid Overdose Events
- Hippocampal volume loss in individuals with a history of non-fatal opioid overdose
- Examining Increasing Racial Inequities in Opioid Overdose Deaths: a Spatiotemporal Analysis of Black and White Decedents in St. Louis, Missouri, 2011-2021
- A Diagram of the Social-Ecological Conditions of Opioid Misuse and Overdose
- Pharmacogenetics of Lethal Opioid Overdose: Review of Current Evidence and Preliminary Results from a Pilot Study
- Risk factors for chronic prescription opioid use in Multiple Sclerosis
- "Naloxone? Not for me!" First cross-assessment by patients and healthcare professionals of the risk of opioid overdose
- Transitions in Prescription Benzodiazepine Use and Misuse and in Substance Use Disorder Symptoms Through Age 50
- Prescription high-risk polysubstance use among opioid maintenance treatment patients
- Higher First 30-Day Dose of Buprenorphine for Opioid Use Disorder Treatment Is Associated With Decreased Mortality
- Prescription opioid use among people with opioid dependence and concurrent benzodiazepine and gabapentinoid exposure: An analysis of overdose and all-cause mortality
- Risks of opioid overdose among New York State Medicaid recipients with chronic pain before and during the COVID-19 pandemic
- Non-overdose acute care hospitalizations for opioid use disorder among commercially-insured adults: a retrospective cohort study
- Examining differences in opioid deaths by race in North Carolina following the STOP Act, 2010-2019
- Receipt of Prescription Psychostimulants and Stimulant-Involved Fatal Overdose: A Population-Based Case-Control Study
- Feasibility and Acceptability of an Overdose Prevention Intervention Delivered by Community Pharmacists for Patients Prescribed Opioids for Chronic Non-Cancer Pain
- Suicide-related care among patients who have experienced an opioid-involved overdose
- High-deductible Health Plans and Nonfatal Opioid Overdose
- Applied risk mapping and spatial analysis of address-level decedent data to inform opioid overdose interventions: The Massachusetts HEALing Communities Study
- Non-fatal overdose risk associated with prescribing opioid agonists concurrently with other medication: Cohort study conducted using linked primary care, secondary care and mortality records
- Development and validation of a community-level social determinants of health index for drug overdose deaths in the HEALing Communities Study
- Association of Disability Status and Type With Binge Drinking and Prescription Opioid Misuse Among Adults From a 3-State Sample
- Procedural Benzodiazepine and Post-Vasectomy Opioid and Nonopioid Prescribing Variation in a Large Health Care System
- Rapid opioid overdose response system technologies
- Nonfatal Overdoses Among Pregnant Individuals With Opioid Use Disorder
- Healthcare costs and use before and after opioid overdose in Veterans Health Administration patients with opioid use disorder
- Differences in adverse outcomes across race and ethnicity among Veterans with similar predicted risks of an overdose or suicide-related event
- Affordable housing through the Low-Income Housing Tax Credit program and opioid overdose emergency department visits
- Trauma-related shame predicts daily non-medical prescription opioid use among individuals with PTSD symptoms
- Psychiatric risk factors for chronic high-dose opioid prescribing: register-based cohort study
- Opioid-related policy changes: Experiences and perspectives from people who use opioids to manage non-cancer chronic pain
- Drug prescriptions preceding opioid-related deaths-a register study in forensic autopsy patients
- Overdose mortality rates for opioids and stimulant drugs are substantially higher in men than in women: state-level analysis
- Identifying Patterns of Pain, Depression, Anxiety, Interpersonal Trauma Exposure, and Nonmedical Prescription Opioid Use: Latent Class Analysis among Patients with Chronic Pain
- Preliminary effectiveness of online opioid overdose and naloxone administration training and impact of naloxone possession on opioid use
- Exploring trends in benzodiazepine-positive fatal drug overdoses in Tennessee, 2019-2021
- Declining but Pronounced State-Level Disparities in Prescription Opioid Distribution in the United States
- A study protocol for a European, mixed methods, prospective, cohort study of the effectiveness of naloxone administration by community members, in reversing opioid overdose: NalPORS
- The Opioid Overdose Resuscitation Education for Addiction Counselors and Trainees (Opioid Overdose REACT) naloxone response education pilot project improved confidence and knowledge among addiction counselors and trainees
- Effects of Workplace Variables on Workers Intentions to Misuse Prescription Opioids
- Dealing with opioid dependence and withdrawal in hospitals
- Opioid Overdose: Limitations in Naloxone Reversal of Respiratory Depression and Prevention of Cardiac Arrest
- We need to talk: The urgent conversation on chronic pain, mental health, prescribing patterns and the opioid crisis
- Perspectives and recommendations of opioid overdose survivors experiencing unsheltered homelessness on housing, overdose, and substance use treatment in Boston, MA
- Change in opioid and buprenorphine prescribers and prescriptions by specialty, 2016-2021
- Cause-Specific Mortality among Patients in Treatment for Opioid Use Disorder in Multiple Settings: A Prospective Comparative Cohort Study
- Psychological profiles and prescription opioid misuse, craving, and withdrawal in people with chronic pain
- Nutritional Status Differs by Prescription Opioid Use among Women of Reproductive Age: NHANES 1999-2018
- Expanding access to Medication for Opioid Use Disorder (MOUD) in jails: A comprehensive program evaluation
- Prevalence and correlates of high-dose opioid use among survivors of head and neck cancer
- Pregnancy-associated homicide, suicide and unintentional opioid-involved overdose deaths, North Carolina 2018-2019
- Opioid and stimulant attributed treatment admissions and fatal overdoses: Using national surveillance data to examine the intersection of race, sex, and polysubstance use, 1992-2020
- Associations of clinical personnel characteristics and controlled substance prescribing practices
- Antecedents of fatal overdose in an adult cohort identified through administrative record linkage in Indiana, 2015-2022
- Blood pressure response to extended-release naltrexone in heroin and prescription opioid users and its implications for cardiovascular morbidity
- Opioid prescriptions among Sami and non-Sami with chronic pain: The SAMINOR 2 Questionnaire Survey and the Norwegian Prescription Database
- The Opioid Epidemic: A Review of the Contributing Factors, Negative Consequences, and Best Practices
- The Clinical Evolutions of Surveillance and Violence During Three Contemporary US Crises: Opioid Overdose, COVID-19, and Racial Reckoning
- Emergency Room Utilization and Methamphetamine Overdose Symptoms Among Syringe Services Program Participants in Washington State
- The End of the X-waiver: Excitement, Apprehension, and Opportunity